Humana (HUM) and Cohere Health Expand Prior Authorization Partnership

Go back to Humana (HUM) and Cohere Health Expand Prior Authorization Partnership

Humana (HUM) PT Lowered to $353 at RBC Capital

April 25, 2024 6:44 AM EDT

RBC Capital analyst Frank Morgan lowered the price target on Humana (NYSE: HUM) to $353.00 (from $415.00) while maintaining a Outperform rating.

The analyst comments "Despite taking 2025 adjusted EPS growth targets off the table for now, management stressed its continued commitment to margin... More

Humana (HUM) PT Lowered to $360 at Cantor Fitzgerald

April 25, 2024 6:32 AM EDT

Cantor Fitzgerald analyst Sarah James lowered the price target on Humana (NYSE: HUM) to $360.00 (from $391.00) while maintaining a Neutral rating.

The analyst comments "On the positive side, HUM beat the quarter (expected by investors) and held 2024 guide (also expected by... More